(Q36607558)

15 August 2017

1 reference

title

Systemic antibiotic therapy of acne vulgaris (English)

1 reference

15 August 2017

Falk Ochsendorf

1

1 reference

15 August 2017

1 October 2006

1 reference

15 August 2017

1 reference

15 August 2017

4

1 reference

15 August 2017

10

1 reference

15 August 2017

828-841

1 reference

Management of acne: a report from a Global Alliance to Improve Outcomes in Acne.

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Effects of Subantimicrobial-Dose Doxycycline in the Treatment of Moderate Acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Treatment of acne with topical antibiotics: lessons from clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Inflammatory events are involved in acne lesion initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Antimicrobial therapy in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Oral antibiotics with antiinflammatory/ immunomodulatory effects in the treatment of various dermatoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Tetracyclines: nonantibiotic properties and their clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Acne therapy: a methodologic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Clinical evaluation of roxithromycin: a double-blind, placebo-controlled and crossover trial in patients with acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Azithromycin monthly pulse vs daily doxycycline in the treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Levofloxacin is effective for inflammatory acne and achieves high levels in the lesions: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Strategy of acne therapy with long-term antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Lymecycline and minocycline in inflammatory acne: a randomized, double-blind intent-to-treat study on clinical and in vivo antibacterial efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Seborrhoea--an indicator for poor clinical response in acne patients treated with antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Antibiotic-resistant acne: lessons from Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Propionibacterium acnes resistance: a worldwide problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Effect of Antibiotics on the Oropharyngeal Flora in Patients With Acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Minocycline-induced staining of torus palatinus and alveolar bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Antibiotic treatment of acne may be associated with upper respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Comparative safety of tetracycline, minocycline, and doxycycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Minocycline-induced lupus. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Systemic antibiotics for acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Phototoxic eruptions due to doxycycline--a dose-related phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

Oral contraceptive efficacy and antibiotic interaction: a myth debunked

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06053.X

10.1111/J.1610-0387.2006.06053.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17010172